Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowFebruary 19, 2026 — 3:45 PM - 4:15 PM ET
Nasdaq MarketSite, 4 Times Square, New York
Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for best-in-class profiles in the largest inflammatory and immunology (I&I) markets, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Michael Henderson, M.D., Chief Executive Officer of Apogee, rings the Closing Bell.
